Ocular immune reconstitution inflammatory syndromes

Current Opinion in HIV and AIDS

Volumn 3, Issue 4, 2008, Pages 432-437

  Otiti Sengeri, Juliet ^a   Meenken, Christina ^b   Van Den Horn, Gerardus J ^c   Kempen, John H ^d  

^a MAKERERE UNIVERSITY   (Uganda)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Jan Van Goyen Medical Center   (Netherlands)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytomegalovirus retinitis; HAART; HIV; Immune recovery uveitis; Ocular diseases

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; FLUOCINOLONE ACETONIDE; TRIAMCINOLONE ACETONIDE; VALGANCICLOVIR;

CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RECOVERY UVEITIS; INFECTION PREVENTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINITIS; REVIEW; RISK ASSESSMENT; UVEITIS;

EID: 67649580479     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328302cc3d     Document Type: Review

References (41)

1. Mocroft A, Lederrgerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29.
2. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002; 81:213-227.
3. Murdoch DM, Venter WD, VanRie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Research and Therapy 2007; 4:9.
4. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000; 1:107-115.
5. Hirsch HH, Kaufmann G, Sendi P, et al. Immune reconstitution in HIV infected patients. Clin Infect Dis 2004; 38:1159-1166.
6. Shelbourne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006; 57:167-170.
7. Lawn SD, French MA. Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource limited settings. Current Opinion in HIV and AIDS 2007; 2:339-345. In this recent overview the implications for the near future concerning IRD in resource limited countries are summarized.
8. Zamir E, Hudson H, Ober RR, Kumar SK, et al. Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? 1. Ophthalmology 2002; 109:2144-2180.
9. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996; 114:821-827.
10. Holland GN, Vaudaux JD, Jeng SM, Yu F, et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1998 to 1994) 2. Am J Ophthalmol 2008; 145:5-11. This article describes the nearly absent inflammation in patients with CMV retinitis before HAART was available, a similar finding in patients who fail on HAART. HAART responders, however, are predisposed to IRU.
11. Van den Horn GJ, Meenken C, Danner SA, et al. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV positive patients. Br J Ophthalmol 1998; 82:988-990.
12. Zegans ME, Walton RC, Holland GN, O'Donnell JJ, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998; 125:292-300.
13. Karavellas MP, Plummer DJ, MacDonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J infectious Dis 1999; 179:697-700.
14. Schrier RD, Song MK, Smith IL, et al. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis. Retina 2006; 26:165-169. This paper explains the pathogenesis of IRU, the role of pathogenic antigens in development of IRU.
15. Kempen JH, Min YI, Freeman WR, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 2006; 113:684-694.
16. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349:1443-1445.
17. Van den Horn GJ, Meenken C, DeSmet MD. Enhanced ocular inflammation can be due to other cause than immune recovery [abstract]. In: Proceedings of Seventh European Conference on Clinical Aspects and Treatment of HIV-infection; 23-27 October 1999; Lisbon. Paris: European AIDS Clinical Society; 1999. Abstract 737.
18. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000; 130:49-56.
19. Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons: 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137:435-478.
20. Kuo IC, Kempen JH, Dunn JP, et al. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 2004; 138:338-346.
21. Sinclair E, Tan QX, Sharp M, Girling V, et al. Protective immunity to cytomegalovirus retinitis in AIDS is associated with CMV specific T cells that express interferon-gamma and inerleukin-2 and have CD8+ cell maturational phenotype. J Infect Dis 2006; 194:1537-1546.
22. Multimer HP, Akatsuka Y, Manely T, et al. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J infectious Dis 2002; 186:701-705.
23. Jabs DA, Van Natta ML, Holbrook JT, et al. Longitudinal study of the ocular complications of AIDS. 2. Ocular examination results at enrollment. Ophthalmology 2007; 114:787-793. A detailed study reported on a large number of patients with AIDS: CMV retinitis and IRU were common in this population.
24. Modorati G, Miserocchi E, Brancato R. Immune recovery uveitis and human leucocyte antigen typing: a report on four patients. Eur J Ophthalmol 2005; 155:607-609.
25. Manabe YC, Campbell JD, Sydnor E, Moore R. Immune reconstitution inflammatory syndrome. Risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46:456-462.
26. French MA. The immunopathogenesis of mycobacterial immune restoration disease. Lancet Infect Dis 2006; 6:461-462.
27. Ortega-Larrocea G, Espinosa E, Reyes-Teran G. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy. AIDS 2005; 19:735-738.
28. Robinson MR, Reed G, Csaky KG, et al. Immune recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000; 130:49-56.
29. Thorne JE, Jabs DA, Kempen JH, et al. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006; 113:1423-1440. This paper reveals risk factors for visual loss in AIDS patients with CMV retinitis on HAART an important clinical significance of IRU.
30. Westeneg AC, Rothova A, De Boer JH, Groot-Mijnes JD. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol 2007; 144:781-785. This paper explains the value of intraocular fluid PCR in the diagnosis of infectious uveitis, this paper is an important diagnostic work up in IRU.
31. Henderson HW, Mitchell SM. Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol 1999; 83:540-545.
32. Karavellas MP, Azen SP, Macdonald C, et al. Immune recovery uveitis and uveitis in AIDS: Clinical predictors, sequelae and treatment outcome. Retina 2001; 21:1-9.
33. El-Bradey M, Cheng L, Song M, et al. Long term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach. Retina 2004; 24:376-382.
34. Morrison VL, Kozak I, Labree LD, et al. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macula oedema. Ophthalmology 2007; 114:334-339. This paper describes the useful effect of intravitreal steroids in treatment of IRU.
35. Sirimaharaj M, Robinson MR, Zhu M, et al. Intravitreal injection of triamcinolone acetonide for immune recovery uveitis. Retina 2006; 26:578-580.
36. Rothova A. Inflammatory cystoid macular oedema. Current Opinion Ophthalmol 2007; 18:487-492. This paper reviews recent developments in treatment of inflammatory cystoid macular oedema, a frequent complication of IRU.
37. Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK. Cytomegalovirus retinitis after fluocinolone acetonide implant. Am J Ophthalmol 2007; 143:334-335.
38. Kosobucki BR, Goldberg DE, Besshok et al. Valganciclovir therapy for immune recovery uveitis complicated by macula oedema. Am J Ophthalmol 2004; 137: 636-638.
39. Kestelyn PG, Cunningham ET. HIV/AIDS and blindness. Bull World Health Organ 2001; 79:208-213.
40. Heiden D, Ford N, Wilson D, et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007; 12:9-18. This paper reveals recent findings on the situation of ocular diseases and CMV retinitis in resource-limited settings. More research is recommended in this region.
41. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med 1993; 329:1922-1926.